The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Hereditary Cancer Testing Market In 2026 And What Value Is Projected For 2030?
The hereditary cancer testing market has seen rapid expansion in recent years. Its size is expected to climb from $4.75 billion in 2025 to $5.3 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. This historical growth is largely due to factors such as increased public awareness of hereditary cancer risks, the widespread availability of next-generation sequencing platforms, the expansion of diagnostic laboratory networks, a rise in physician recommendations for genetic testing, and the emergence of personalized risk assessment models.
The hereditary cancer testing market is projected to experience substantial expansion over the coming years. This market is set to reach a value of $8.02 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.9%. This anticipated growth during the forecast period stems from several factors, including the broadened scope of population-scale genetic screening, the escalating application of AI-driven genomic analysis, a rise in preventive oncology initiatives, increased consumer desire for economical testing options, and bolstered regulatory backing for genetic diagnostics. Key developments expected within this period encompass a greater uptake of multi-gene panel testing, an escalating need for identifying cancer risks at an early stage, the wider deployment of sophisticated genetic sequencing technologies, the expansion of programs focused on preventive testing, and improved incorporation of clinical decision support mechanisms.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8121&type=smp
What Key Drivers Are Influencing The Growth Of The Hereditary Cancer Testing Market?
The hereditary cancer testing market is projected to expand significantly due to an increasing global cancer burden. Cancer is defined as a group of diseases characterized by the uncontrolled and abnormal proliferation of cells, which have the potential to invade and spread to other tissues and parts of the body, contrasting with the regulated growth, division, and death processes in healthy organisms. Hereditary cancer testing plays a vital role in addressing the overall impact of cancer by identifying individuals with a genetic predisposition to particular cancers. Through the assessment of inherited mutations and familial risk factors, this testing helps identify those at higher risk, thereby enabling early intervention, personalized treatment strategies, and proactive preventive measures. For instance, in July 2024, data from the Australian Institute of Health and Welfare, an Australia-based government agency, showed that the number of cancer cases diagnosed in Australia rose from 160,570 in 2022 to 164,694 in 2023, marking a notable increase over the year. This upward trend highlights the growing prevalence of cancer within the country. Thus, the escalating overall cancer burden is a key driver for the hereditary cancer testing market.
What Are The Key Segments Of The Hereditary Cancer Testing Market?
The hereditary cancer testing market covered in this report is segmented –
1) By Test Type: Multi Panel Test, Single-Site Genetic Test
2) By Indication: Breast Cancer, Ovarian Cancer, Colorectal Cancer, Other Indications
3) By End user: Hospital, Clinics, Diagnostic Centers
Subsegments:
1) By Multi Panel Test: Comprehensive Genetic Panels, Targeted Gene Panels
2) By Single-Site Genetic Test: Specific Gene Testing, Familial Mutation Testing
What Key Trends Are Influencing The Development Of The Hereditary Cancer Testing Market?
Major companies operating in the hereditary cancer testing market are concentrating on innovative technologies, like molecular diagnostic tumor testing, to improve accuracy, elevate patient outcomes, and tailor treatment strategies. Molecular diagnostic tumor testing involves analyzing a tumor’s genetic and molecular characteristics to inform therapeutic decisions and forecast prognoses. For instance, in February 2023, Chubb Business Services India Private Limited, an India-based global insurance company, introduced Cancer Advocate Plus. This program incorporates genetics-based testing to pinpoint inherited genes that heighten cancer risk. This forward-thinking approach enables individuals to understand their predisposition to various cancers, thus facilitating early intervention and customized care strategies.
Who Are The Leading Companies Operating In The Hereditary Cancer Testing Market?
Major companies operating in the hereditary cancer testing market are Centogene NV, Ambry Genetics Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Quest Diagnostics, PreventionGenetics, Fulgent Genetics Inc., Invitae Corporation, Medical Diagnostic Laboratories LLC, Natera Inc., Color Health Inc., CooperSurgical Inc., OPKO Health Inc., Illumina Inc., Laboratory Corporation of America Holdings, Pathway Genomics Corporation, Strand Life Sciences Private Limited, Progenity Inc., Myogenes Ltd., Associated Regional and University Pathologists Inc., 4baseCare, Biocartis Group NV, F. Hoffmann-La Roche AG, Medgenome Pvt. Ltd., Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies PLC, PerkinElmer Inc.
Read the full hereditary cancer testing market report here:
https://www.thebusinessresearchcompany.com/report/hereditary-cancer-testing-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Hereditary Cancer Testing Market?
North America was the largest region in the hereditary cancer testing market in 2025. The regions covered in the hereditary cancer testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Hereditary Cancer Testing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8121&type=smp
Browse Through More Reports Similar to the Global Hereditary Cancer Testing Market 2026, By The Business Research Company
Genetic Testing Global Market Report
https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report
Hereditary Breast And Ovarian Cancer Syndrome Treatment Global Market Report
Genetic Toxicology Testing Global Market Report
https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model